Xcout Intel
Janssen Pharmaceutical Companies of Johnson & Johnson
The Janssen Pharmaceutical Companies are part of Johnson & Johnson, focusing on innovative medicine. They were founded as pharmaceutical companies and have a history of developing new treatments.
Subscribe to see Janssen Pharmaceutical Companies of Johnson & Johnson’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Janssen Pharmaceutical Companies of Johnson & Johnson at a glance
Janssen Pharmaceutical Companies of Johnson & Johnson is a pharmaceuticals company headquartered in Singapore. Xcout tracks 21 named people at Janssen Pharmaceutical Companies of Johnson & Johnson, including Joaquin Duato (Chairman and Chief Executive Officer).
Janssen Pharmaceutical Companies of Johnson & Johnson leadership
- Joaquin DuatoChairman and Chief Executive Officer
- Joseph J. WolkExecutive Vice President, Chief Financial Officer
- Elizabeth ForminardExecutive Vice President, Chief Legal Officer
- James SwansonExecutive Vice President, Chief Information Officer
- Kathryn E WengelExecutive Vice President, Chief Technical Operations and Risk Officer
- Kristen MulhollandExecutive Vice President, Chief Human Resources Officer
15 more named people on record for Janssen Pharmaceutical Companies of Johnson & Johnson, with roles, board committees and tenure — see the full roster →
Janssen Pharmaceutical Companies of Johnson & Johnson competitors
A few of Janssen Pharmaceutical Companies of Johnson & Johnson's closest competitors — see the full list of competitors and alternatives →
Johnson & Johnson researches, develops, and delivers innovative medicines, therapies, and medical technology devices. The company focuses on healthcare areas such as oncology, neuroscience, immunology, cardiovascular diseases, orthopaedics, and surgery to serve patients globally.
Novartis is a global healthcare company that researches, develops, and manufactures innovative medicines across therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular diseases. The company serves patients, healthcare professionals, and healthcare systems worldwide by providing pharmaceutical treatments and managing clinical trials.
Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and delivers innovative medicines to help patients prevail over serious diseases. The company focuses on therapeutic areas including oncology, hematology, neuroscience, immunology, and cardiovascular research.
Servier is an international pharmaceutical company that researches, develops, and provides medical treatments primarily focused on oncology, cardio-metabolic diseases, and neurology. The company serves patients globally by delivering therapeutic innovations and advancing research in areas such as rare diseases and chronic conditions.
Get Janssen Pharmaceutical Companies of Johnson & Johnson's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Janssen Pharmaceutical Companies of Johnson & Johnson? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Janssen Pharmaceutical Companies of Johnson & Johnson in Xcout Intel
- 21 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access